First Time Getting GLP-1? Complete Beginner's Guide
Complete guide covering starting GLP-1 treatment for the first time in 2026. Compare options and see how compounded GLP-1 treatment through telehealth works.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This article provides comprehensive, medically reviewed information about starting GLP-1 treatment for the first time to help patients make informed treatment decisions.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Understanding First Time Getting GLP-1? Complete Beginner's Guide
This article examines starting GLP-1 treatment for the first time in the context of this evolving market, providing patients with the information they need to evaluate their options and make decisions that align with their health goals and financial reality. Whether you are considering semaglutide or tirzepatide, understanding the current landscape is essential for making an informed choice.
Frequently Asked Questions
How do compounded GLP-1 medications compare to brand-name options?
Brand-name products like Wegovy, Ozempic, Mounjaro, and Zepbound are FDA-approved finished drugs made by their manufacturers. Compounded semaglutide and compounded tirzepatide are prepared by state-licensed compounding pharmacies against an individual prescription and are not FDA-approved as drugs. The two categories also differ in delivery device, supply chain, and price. Whether a compounded preparation is appropriate for you is a decision for your prescribing clinician.
Do I need insurance to get compounded GLP-1 medications?
No, compounded GLP-1 medications through Trimi do not require insurance coverage.
How do I get started with compounded GLP-1 treatment?
Through Trimi, the process starts with an online health assessment covering your medical history, medications, and weight loss goals. A licensed provider typically reviews your completed information within 12–24 hours and prescribes medication only if clinically appropriate.
Can I switch from a brand-name medication to compounded?
Switching from a brand-name GLP-1 to a compounded preparation is a clinical decision for your prescribing provider, who will review your treatment history and set the appropriate dose and titration schedule. Brand-name products are FDA-approved finished drugs, while compounded preparations are prepared by state-licensed pharmacies against an individual prescription and are not FDA-approved as drugs. Patients considering a switch should discuss the tradeoffs with their provider.
Sources & References
- STEP 1 trial: semaglutide 2.4mg for weight management (NEJM, 2021).
- SURMOUNT-1 trial: tirzepatide for obesity (NEJM, 2022).
- FDA guidance on drug compounding regulations.
- FDA drug shortage database.
- NABP compounding pharmacy accreditation standards.
- NIDDK overview of prescription weight loss medications.
- Wegovy prescribing information from the FDA.
- Zepbound prescribing information from the FDA.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi provides compounded GLP-1 medications, this article aims to be informative and balanced, but readers should be aware of our perspective.